Treating hormonal acne effectively requires a multi-pronged approach that targets the underlying androgen-driven stimulation of sebaceous glands. For mild to moderate cases, topical retinoids such as adapalene are considered the first-line gold standard, as they normalise follicular keratinisation and reduce microcomedone formation [1]. These are often paired with benzoyl peroxide to address superfical C. acnes colonisation. However, because hormonal acne is frequently recalcitrant to topical therapy alone, Australian clinical guidelines often recommend systemic interventions to regulate sebum production at the source [2].
For female patients, oral anti-androgens like spironolactone or specific combined oral contraceptive pills (COCPs) are highly effective. These medications work by blocking androgen receptors or decreasing the circulation of free testosterone, thereby reducing the oil production that fuels cystic lesions along the jawline [3]. Supplementing these medical treatments with a barrier-repair focused skincare routine, including non-comedogenic moisturisers and gentle cleansers, is essential to minimise the irritation often associated with clinical-grade topicals [1].
Hormonal acne, often clinically termed 'adult female acne', is characterised by its distribution—primarily the lower third of the face, jawline, and neck—and its cyclical nature. From a pathophysiological perspective, it is driven by an exaggerated response of the pilosebaceous unit to circulating androgens, particularly dihydrotestosterone (DHT) [4]. This leads to sebaceous gland hypertrophy and an altered lipid profile within the sebum, promoting a pro-inflammatory environment and follicular occlusion.
Furthermore, the role of Insulin-like Growth Factor 1 (IGF-1) is increasingly recognised in the pathogenesis of hormonal breakouts. Elevated IGF-1 levels, often influenced by high-glycaemic diets, can stimulate androgen synthesis and further exacerbate sebum hypersecretion [5]. Understanding this endocrine-skin axis is crucial for developing a comprehensive management plan that moves beyond surface-level treatments to address the internal biochemical triggers.
For those navigating the complexities of hormonal congestion, Surface Purify offers a gentle yet effective way to manage surface debris with salicylic acid and bakuchiol. To support the skin’s recovery following these targeted treatments, our Balance Biome Crème includes niacinamide and ferments to help maintain a resilient and calm complexion.
FAQ
Does diet impact hormonal acne?
Yes, emerging evidence suggests that high-glycaemic load diets can stimulate the secretion of insulin and IGF-1, both of which amplify androgen activity and sebocyte proliferation [5]. Some studies also indicate that dairy consumption, particularly skim milk, may contain bioactive precursors that further trigger hormonal pathways in the skin [6].
Why is hormonal acne common in the late 20s and 30s?
This phenomenon is often due to 'adult-onset' hormonal fluctuations or a heightened sensitivity of skin receptors to normal androgen levels. Stress-induced cortisol spikes can also stimulate the adrenal glands to produce more androgens, leading to breakouts well past the teenage years [4].
Can topical spironolactone help?
Topical spironolactone is an emerging treatment that offers a localised anti-androgenic effect without the systemic side effects of the oral version. Research suggests it can significantly reduce sebum excretion rates and inflammatory lesion counts when used consistently [7].
References:
[1] Thielitz A, et al. Journal of the European Academy of Dermatology and Venereology. 2015;29(S5):1-7. doi:10.1111/jdv.13176
[2] Australasian College of Dermatologists. Acne Management Guide. 2022; Clinical Practice series.
[3] Kim GK, et al. The Journal of Clinical and Aesthetic Dermatology. 2012;5(3):37-50.
[4] Bagatin E, et al. International Journal of Women's Dermatology. 2019;5(1):19-25. doi:10.1016/j.ijwd.2018.09.001
[5] Smith RN, et al. American Journal of Clinical Nutrition. 2007;86(1):107-115. doi:10.1093/ajcn/86.1.107
[6] Adebamowo CA, et al. Journal of the American Academy of Dermatology. 2005;52(2):207-214. doi:10.1016/j.jaad.2004.08.007
[7] Afzali BM, et al. Journal of Dermatological Treatment. 2012;23(1):21-25. doi:10.3109/09546631003801619
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new skincare regimen. Content reviewed by a biomedical scientist.
